Prostate Cancer
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study.
November 1, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu-PSMA-617.
November 1, 2024
PSMA PET/CT Accuracy in Diagnosing Prostate Cancer Nodes Metastases.
November 1, 2024
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes.
November 1, 2024
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
October 30, 2024
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.
October 30, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
October 30, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
October 30, 2024
Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer.
October 30, 2024
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
October 30, 2024
What's in a Name? Why Words Matter in Advanced Prostate Cancer.
October 30, 2024